HRT Financial’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-183,424
| Closed | -$1.31M | – | 3084 |
|
2025
Q1 | $1.31M | Sell |
183,424
-179,979
| -50% | -$1.29M | 0.01% | 857 |
|
2024
Q4 | $2.81M | Buy |
363,403
+129,404
| +55% | +$1M | 0.01% | 512 |
|
2024
Q3 | $2.45M | Buy |
+233,999
| New | +$2.45M | 0.01% | 750 |
|
2024
Q1 | – | Sell |
-15,828
| Closed | -$284K | – | 2789 |
|
2023
Q4 | $284K | Buy |
+15,828
| New | +$284K | ﹤0.01% | 1506 |
|
2023
Q3 | – | Sell |
-18,939
| Closed | -$378K | – | 2721 |
|
2023
Q2 | $378K | Buy |
+18,939
| New | +$378K | ﹤0.01% | 1361 |
|
2023
Q1 | – | Sell |
-44,462
| Closed | -$1.01M | – | 2875 |
|
2022
Q4 | $1.01M | Buy |
44,462
+36,711
| +474% | +$832K | 0.01% | 897 |
|
2022
Q3 | $204K | Buy |
+7,751
| New | +$204K | ﹤0.01% | 2032 |
|
2021
Q1 | – | Sell |
-6,895
| Closed | -$312K | – | 2854 |
|
2020
Q4 | $312K | Sell |
6,895
-25,514
| -79% | -$1.15M | 0.01% | 1204 |
|
2020
Q3 | $891K | Buy |
+32,409
| New | +$891K | 0.03% | 558 |
|
2020
Q1 | – | Sell |
-8,317
| Closed | -$340K | – | 1144 |
|
2019
Q4 | $340K | Buy |
+8,317
| New | +$340K | 0.01% | 646 |
|